Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Henry

Showing results (601-610 of 647) with videos related to

Pageof 65
Sort By:
Scientific Reports|June 26, 2019
Small Molecule IL-36γ Antagonist as a Novel Therapeutic Approach for Plaque PsoriasisViktor Todorović, Zhi Su, C Brent Putman, et al.
Revue Medicale De Liege|July 8, 1999
[Cutaneous melanomas, a spectrum of emerging cancers in women of Wallonia. Outlook by the Mosan Study Group of Pigmented Neoplasms]C Piérard-Franchimont, J E Arrese, F Cornil, et al.
Journal of Medicinal Chemistry|May 19, 2026
Discovery of Fosigotifator, a Potent eIF2B Activator with Desired Properties for Human StudiesJennifer M Frost, Yunsong Tong, Xiangdong Xu, et al.
Journal of Medicinal Chemistry|May 28, 2004
Synthesis and structure-activity relationships of a novel series of 2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide K(ATP) channel openers: discovery of (-)-(9S)-9-(3-bromo-4-fluorophenyl)-2,3,5,6,7,9- hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637), a potent K(ATP) opener that selectively inhibits spontaneous bladder contractionsWilliam A Carroll, Robert J Altenbach, Hao Bai, et al.
Environmental Health Perspectives|January 6, 2011
Toward identifying the next generation of superfund and hazardous waste site contaminantsWendell P Ela, David L Sedlak, Morton A Barlaz, et al.
Journal of Medicinal Chemistry|February 20, 2009
Inhibitors of hepatitis C virus polymerase: synthesis and biological characterization of unsymmetrical dialkyl-hydroxynaphthalenoyl-benzothiadiazinesRolf Wagner, Daniel P Larson, David W A Beno, et al.
Journal of Medicinal Chemistry|January 5, 2007
Discovery and metabolic stabilization of potent and selective 2-amino-N-(adamant-2-yl) acetamide 11beta-hydroxysteroid dehydrogenase type 1 inhibitorsJeffrey J Rohde, Marina A Pliushchev, Bryan K Sorensen, et al.
Journal of Medicinal Chemistry|April 7, 2023
Correction to "Discovery of ABBV-3373, an Anti-TNF Glucocorticoid Receptor Modulator Immunology Antibody Drug Conjugate"Adrian D Hobson, Michael J McPherson, Martin E Hayes, et al.
Journal of Medicinal Chemistry|November 17, 2022
Discovery of ABBV-3373, an Anti-TNF Glucocorticoid Receptor Modulator Immunology Antibody Drug ConjugateAdrian D Hobson, Michael J McPherson, Martin E Hayes, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1982
Antihypertensive therapy in patients above age 60 with systolic hypertension. A progress report of the European Working Party on High Blood Pressure in the Elderly (EWPHE)A Amery, W Birkenhäger, M Bogaert, et al.
Pageof 65

Showing results (601-610 of 647) with videos related to

Sort By:
Pageof 65
Scientific Reports|June 26, 2019
Small Molecule IL-36γ Antagonist as a Novel Therapeutic Approach for Plaque PsoriasisViktor Todorović, Zhi Su, C Brent Putman, et al.
Revue Medicale De Liege|July 8, 1999
[Cutaneous melanomas, a spectrum of emerging cancers in women of Wallonia. Outlook by the Mosan Study Group of Pigmented Neoplasms]C Piérard-Franchimont, J E Arrese, F Cornil, et al.
Journal of Medicinal Chemistry|May 19, 2026
Discovery of Fosigotifator, a Potent eIF2B Activator with Desired Properties for Human StudiesJennifer M Frost, Yunsong Tong, Xiangdong Xu, et al.
Journal of Medicinal Chemistry|May 28, 2004
Synthesis and structure-activity relationships of a novel series of 2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide K(ATP) channel openers: discovery of (-)-(9S)-9-(3-bromo-4-fluorophenyl)-2,3,5,6,7,9- hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637), a potent K(ATP) opener that selectively inhibits spontaneous bladder contractionsWilliam A Carroll, Robert J Altenbach, Hao Bai, et al.
Environmental Health Perspectives|January 6, 2011
Toward identifying the next generation of superfund and hazardous waste site contaminantsWendell P Ela, David L Sedlak, Morton A Barlaz, et al.
Journal of Medicinal Chemistry|February 20, 2009
Inhibitors of hepatitis C virus polymerase: synthesis and biological characterization of unsymmetrical dialkyl-hydroxynaphthalenoyl-benzothiadiazinesRolf Wagner, Daniel P Larson, David W A Beno, et al.
Journal of Medicinal Chemistry|January 5, 2007
Discovery and metabolic stabilization of potent and selective 2-amino-N-(adamant-2-yl) acetamide 11beta-hydroxysteroid dehydrogenase type 1 inhibitorsJeffrey J Rohde, Marina A Pliushchev, Bryan K Sorensen, et al.
Journal of Medicinal Chemistry|April 7, 2023
Correction to "Discovery of ABBV-3373, an Anti-TNF Glucocorticoid Receptor Modulator Immunology Antibody Drug Conjugate"Adrian D Hobson, Michael J McPherson, Martin E Hayes, et al.
Journal of Medicinal Chemistry|November 17, 2022
Discovery of ABBV-3373, an Anti-TNF Glucocorticoid Receptor Modulator Immunology Antibody Drug ConjugateAdrian D Hobson, Michael J McPherson, Martin E Hayes, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1982
Antihypertensive therapy in patients above age 60 with systolic hypertension. A progress report of the European Working Party on High Blood Pressure in the Elderly (EWPHE)A Amery, W Birkenhäger, M Bogaert, et al.
Pageof 65